Breakthrough Treatment for Hepatitis C Shows 100% Success

Antioxidant May Offer Neuroprotection in Multiple Sclerosis
May 4, 2016
Study Shows Potential of Novel Compound to Treat Multiple Sclerosis
May 5, 2016
Show all

Breakthrough Treatment for Hepatitis C Shows 100% Success

A promising new study found excellent results with a new drug combination for the treatment of hepatitis C.

Hepatits C, the dangerously transmittable disease prevalent in Africa and Asia, may have just met its match.

A new study published at The International Liver Congress in Barcelona, Spain presented the results of a 6-week treatment program involving 20 patients using a 2 drug combination, which was approved for use by the FDA two years ago: sofosbuvir and ledipasvir in pill form.

After a 12-week follow-up, 95% of the patients had zero traces of HCV in their systems.

Since acute hepatitis C rarely reveals early symptoms, the disease has been spread to as many as 200 million people worldwide, whether from sexual contact or shared needles. Lack of treatment can consequently lead to serious liver disease and damage.

“These exciting findings open up short and cost-effective treatment options that could prevent the spread of HCV in high risk populations,” said Professor Frank Tacke, a Governing Board member of European Association for the Study of the Liver (EASL). “We look forward to seeing this pilot study extended so the findings can be validated and then hopefully used as a tool to change clinical practice for the better.”

Read Full Article: Breakthrough Treatment for Hepatitis C Shows 100% Success – Good News Network


The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.